COLTENE Holding AG (CLHLF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 20.47 means the share price is 20.47 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $365M is the value of all shares combined. Beta 0.83: the stock has moved about 17% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCOLTENE Holding AG (CLHLF) trades at $61.16. Market cap: $365M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for CLHLF: CLHLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLHLF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
CLHLF: 1/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
COLTENE Holding AG (CLHLF) Healthcare & Pipeline Overview
COLTENE Holding AG is a global manufacturer and distributor of dental consumables and equipment, serving dentists and laboratories across diverse product categories including restoration, endodontics, and infection control. Headquartered in Switzerland, the company leverages a broad geographic footprint and a diversified product portfolio within the specialized medical instruments and supplies sector.
What Is the Investment Thesis for CLHLF?
COLTENE Holding AG presents a compelling profile within the dental instruments and supplies sector, characterized by its global operational footprint and diversified product portfolio. With a market capitalization of $365M, the company demonstrates a stable financial foundation, supported by a P/E ratio of 20.47 and a gross margin of 46.2%, indicating efficient cost management relative to its revenue. The profit margin of 6.2% reflects its ability to convert sales into net income. A Beta of 0.83 suggests lower volatility compared to the broader market, potentially appealing to investors seeking stability. Furthermore, a dividend yield of 4.01% offers income generation potential. Key growth catalysts include the increasing global demand for dental care, driven by an aging population and rising awareness of oral health, particularly in emerging markets where COLTENE has established presence. The company's continuous innovation in product categories like CAD/CAM solutions and advanced restorative materials positions it to capture market share in evolving digital dentistry trends. Its comprehensive offerings across restoration, endodontics, prosthetics, and infection control provide resilience against fluctuations in demand for any single product line, underpinning its long-term value proposition.
Based on FMP financials and quantitative analysis
CLHLF Key Highlights
Market Capitalization of $365M, reflecting its position as a specialized player in the global dental supplies market.
- P/E ratio of 20.47, indicating investor confidence in its earnings potential relative to its current share price.
- Gross Margin of 46.2%, demonstrating strong cost control in manufacturing and efficient pricing strategies for its dental products.
- Profit Margin of 6.2%, showcasing its ability to generate net income from its global sales operations.
- Dividend Yield of 4.01%, providing shareholders with a consistent return on investment, indicative of a mature and stable business model.
Who Are CLHLF's Competitors?
CLHLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| SMTI Sanara MedTech Inc. | $35.03 | 0.00% | $322M | 355-pillar |
| NNNN Anbio Biotechnology | $6.29 | -3.30% | $276M | 575-pillar |
| INFU InfuSystem Holdings, Inc. | $12.07 | -0.41% | $244M | 865-pillar |
| OSUR OraSure Technologies, Inc. | $3.23 | -3.87% | $222M | 315-pillar |
| UTMD Utah Medical Products, Inc. | $69.64 | -0.11% | $222M | 865-pillar |
| ANGO AngioDynamics, Inc. | $15.34 | +0.66% | $634M | 385-pillar |
| PDEX Pro-Dex, Inc. | $59.84 | -1.42% | $191M | 815-pillar |
| QDEL QuidelOrtho Corporation | $12.15 | -3.88% | $829M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLHLF's Key Strengths?
Diversified product portfolio covering multiple dental specialties, reducing reliance on single product lines.
- Extensive global presence across Europe, Americas, Africa, Middle East, and Asia/Oceania.
- Strong gross margin of 46.2% indicates efficient production and pricing power.
- Consistent dividend yield of 4.01% suggests financial stability and commitment to shareholder returns.
What Are CLHLF's Weaknesses?
Relatively small market capitalization of $365M compared to larger industry players, potentially limiting scale advantages.
- Reliance on the highly specialized and competitive dental market, subject to economic fluctuations affecting elective procedures.
- Disclosure status on the OTC market is 'Unknown', which can hinder investor confidence and transparency.
- Lower profit margin of 6.2% compared to its gross margin, suggesting potential inefficiencies in operating expenses.
What Could Drive CLHLF Stock Higher?
CLHLF catalyst: **Product Innovation and Launches**: The introduction of new, advanced dental materials or equipment, particularly in high-growth areas like CAD/CAM or specialized endodontics, could drive increased sales and market share.
- **Geographic Market Penetration**: Continued expansion and strengthening of distribution channels in emerging markets across Asia/Oceania, Latin America, and the Middle East could unlock significant new revenue streams.
- **Strategic Partnerships or Acquisitions**: Any announcements of collaborations with dental technology firms or acquisitions of complementary businesses could enhance COLTENE's product portfolio and market reach.
- **Increased Global Dental Care Demand**: Sustained growth in global dental visits and procedures, driven by demographic trends and greater oral health awareness, will directly benefit COLTENE's core business.
- **Positive Regulatory Developments**: Favorable regulatory approvals for new products in key markets or streamlined compliance processes could accelerate market entry and reduce operational hurdles.
What Are the Key Risks for CLHLF?
**Economic Downturn Impact**: A significant global or regional economic recession could lead to reduced consumer spending on elective dental procedures, negatively impacting demand for COLTENE's products.
- **Intense Competitive Landscape**: The dental instruments and supplies market is highly competitive, with larger players and niche specialists. COLTENE faces continuous pressure on pricing and market share.
- **Supply Chain Disruptions**: Reliance on a global supply chain for raw materials and manufacturing components exposes COLTENE to risks from geopolitical events, natural disasters, or logistical challenges, potentially affecting production and costs.
- **Regulatory Changes and Compliance Costs**: Evolving and stringent regulatory requirements in different international markets (e.g., medical device regulations) can increase compliance costs, delay product launches, or restrict market access.
- **Currency Fluctuations**: As a company with global operations and sales across various currencies, COLTENE is exposed to foreign exchange rate fluctuations, which can impact reported revenues and profitability.
What Are the Growth Opportunities for CLHLF?
- Growth opportunity 1: **Expansion in Emerging Markets**: COLTENE's established presence across Europe, the Middle East, Africa, Latin America, and Asia/Oceania positions it to capitalize on the rapidly expanding dental care markets in these regions. As disposable incomes rise and awareness of oral health increases, the demand for quality dental products and services is projected to grow significantly. By leveraging its existing distribution networks and tailoring product offerings to local market needs, COLTENE can capture a larger share of these developing markets, which often exhibit higher growth rates compared to mature economies. This strategic focus could drive substantial revenue growth over the next 5-10 years as dental infrastructure and patient access continue to improve.
- Growth opportunity 2: **Innovation in Digital Dentistry Solutions**: The dental industry is undergoing a significant transformation with the increasing adoption of digital technologies, including CAD/CAM solutions. COLTENE already offers CAD/CAM products within its restoration portfolio. Further investment in research and development to enhance its digital dentistry offerings, such as advanced scanning materials, milling blocks, and software integration, could open new revenue streams. This aligns with the industry trend towards more efficient, precise, and patient-friendly dental procedures, providing a competitive advantage and market leadership in a segment expected to see robust growth over the next decade.
- Growth opportunity 3: **Increased Demand for Infection Control Products**: The ongoing global emphasis on hygiene and infection prevention in healthcare settings, particularly post-pandemic, presents a sustained growth opportunity. COLTENE's infection control product line, including ultrasonic cleaning units, patient bibs, and sterile covers, is directly relevant to this trend. Expanding this portfolio with new, innovative solutions and increasing market penetration in both established and new geographies can meet this heightened demand. This segment is likely to experience consistent growth as dental practices prioritize patient and staff safety, ensuring a stable revenue stream in the coming years.
- Growth opportunity 4: **Product Portfolio Diversification and Enhancement**: COLTENE's extensive product range across restoration, endodontics, prosthetics, and treatment auxiliaries provides a strong foundation. Continuous investment in enhancing existing products through material science advancements and introducing new, specialized tools can drive organic growth. For instance, developing next-generation composites with improved aesthetics or durability, or more efficient endodontic instruments, can attract new customers and increase market share. This strategy ensures COLTENE remains at the forefront of dental innovation, catering to evolving professional needs and maintaining relevance in a dynamic market over the medium to long term.
- Growth opportunity 5: **Strategic Acquisitions and Partnerships**: Given the fragmented nature of the dental supplies market, strategic acquisitions of smaller, innovative companies or partnerships with technology providers could significantly bolster COLTENE's market position and expand its product offerings. Acquiring companies with complementary product lines or advanced technological capabilities could accelerate market entry into new niches or strengthen existing ones. Such inorganic growth initiatives could provide access to new customer bases, intellectual property, and distribution channels, contributing to accelerated revenue growth and enhanced competitive advantage over the next 3-7 years.
What Are CLHLF's Competitive Advantages?
- **Extensive Product Portfolio**: A broad range of specialized products across multiple dental disciplines (restoration, endodontics, prosthetics, infection control) creates a comprehensive offering that fosters customer loyalty and simplifies procurement for dental professionals.
- **Global Distribution Network**: Established presence and distribution channels across multiple continents provide significant market reach and operational efficiency, making it challenging for new entrants to replicate.
- **Brand Reputation and Quality**: Long-standing presence and focus on quality in the dental instruments and supplies sector builds trust and preference among dental professionals, who rely on consistent performance for patient care.
- **R&D and Innovation**: Continuous investment in research and development to introduce new and improved products, such as advanced composites and CAD/CAM solutions, helps maintain a competitive edge and addresses evolving industry needs.
- **Regulatory Compliance Expertise**: Navigating complex global regulatory environments for medical devices and supplies (e.g., CE marking, FDA) is a barrier to entry for competitors and ensures market access for COLTENE's products.
What Does CLHLF Do?
COLTENE Holding AG, incorporated in 2005 and headquartered in Altstätten, Switzerland, has established itself as a significant player in the global dental market. Initially known as Medisize Holding AG, the company rebranded to COLTENE Holding AG in April 2008, signifying its focused evolution within the dental industry. COLTENE develops, manufactures, and sells an extensive array of disposables, tools, and equipment tailored for dentists and dental laboratories across a wide international footprint, encompassing Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. Its product offerings are meticulously categorized to address various aspects of dental practice. The restoration segment includes advanced materials like conventional and bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting agents, curing lights, and characterization products. For endodontics, COLTENE provides essential items such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and various endo accessories. The prosthetics line features bite registration materials, retractions, A-silicones, C-silicones, and related accessories. Furthermore, the company supplies critical treatment auxiliaries, including dental rolls and dispensers, cotton pellets, aspirator tips, dental dams and kits, clamps, dental scalers, electrosurgery units, and occlusion verification products. Infection control is another vital area, with products like ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers. COLTENE also manufactures rotary instruments, such as diamond and carbide burs, polishers, and kits, alongside a comprehensive range of laboratory products, including gingiva masks, lab putty, model making products, waxes, occlusion control items, and HP burs. This broad and specialized product portfolio underscores COLTENE's commitment to supporting dental professionals with high-quality, essential supplies and equipment.
What Products and Services Does CLHLF Offer?
- Develop, manufacture, and sell a wide range of dental disposables, tools, and equipment.
- Offer restoration products including composites, CAD/CAM solutions, bondings, and curing lights.
- Provide endodontics products such as rotary files, irrigation solutions, and obturation materials.
- Supply prosthetics like bite registration materials, retractions, and A/C-silicones.
- Manufacture treatment auxiliaries including dental rolls, aspirator tips, and dental dams.
- Produce infection control products such as ultrasonic cleaning units and sterile covers.
- Offer rotary instruments including diamond and carbide burs, and various polishers.
- Develop laboratory products like gingiva masks, lab putty, and model making materials.
- Distribute products globally across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania.
How Does CLHLF Make Money?
- Research, develop, and innovate dental products to meet evolving industry needs.
- Manufacture a diverse portfolio of dental consumables, instruments, and equipment in-house.
- Distribute products through a global sales network to dentists and dental laboratories.
- Generate revenue from direct sales of its specialized dental products across multiple international markets.
- Focus on high-quality, essential items that are regularly consumed or replaced in dental practices.
What Industry Does CLHLF Operate In?
COLTENE Holding AG operates within the Medical - Instruments & Supplies industry, a segment of the broader Healthcare sector that is characterized by consistent demand driven by demographic shifts and advancements in medical technology. The global dental market, a key sub-segment, is experiencing steady growth, fueled by an aging population requiring more complex dental procedures, increasing disposable incomes in emerging economies leading to greater access to dental care, and heightened aesthetic consciousness. COLTENE's positioning as a developer, manufacturer, and seller of a wide range of dental disposables, tools, and equipment places it directly within this growth trajectory. The competitive landscape is fragmented, featuring both large multinational corporations and specialized niche players. COLTENE differentiates itself through its comprehensive product portfolio spanning restoration, endodontics, prosthetics, and infection control, alongside a broad geographic reach across multiple continents. This diversification helps mitigate risks associated with reliance on a single product category or regional market, allowing it to capitalize on various market trends, such as the increasing adoption of digital dentistry solutions and the ongoing emphasis on infection control in healthcare settings.
Who Are CLHLF's Key Customers?
- General dentists and dental specialists (e.g., endodontists, prosthodontists).
- Dental laboratories that create custom dental prosthetics and appliances.
- Dental schools and educational institutions for training purposes.
- Dental supply distributors and wholesalers who then sell to end-users.
- Hospitals and clinics with dental departments.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in CHF, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 49 |
| 2026-08-26 | 49 |
| 2026-08-29 | 49 |
| 2026-09-01 | 49 |
| 2026-09-04 | 49 |
| 2026-09-07 | 49 |
| 2026-09-10 | 49 |
What changed?
The score has stayed at 49.
Over the same 18 days the stock moved +0.0%.
COLTENE Holding AG (CLHLF) Valuation Context
Valued at $365M, CLHLF is classified as a small-cap stock.
CLHLF Revenue & Earnings Trend
In Q2 FY2026, CLHLF generated $138.3M in top-line revenue, marking a sequential decrease of 7.5%. The company recorded net income of $5.0M, with diluted EPS of $0.83. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, CLHLF averaged $1.49 in diluted EPS.
Company Profile
COLTENE Holding AG operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Altstätten, CH. The company is led by CEO Dominik Arnold. CLHLF has traded publicly since 2015.
Key Financial Metrics
Return on equity for COLTENE Holding AG stands at 15.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.1%, showing how much profit it generates from its asset base. CLHLF trades at a trailing price-to-earnings ratio of 20.47, roughly in line with the Healthcare sector average of ~21.50x. Its free cash flow yield is 3.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.9%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
COLTENE Holding AG's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.70 places it in the safe zone, indicating low near-term bankruptcy risk.
CLHLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified product portfolio covering multiple dental specialties, reducing reliance on single product lines.
- Extensive global presence across Europe, Americas, Africa, Middle East, and Asia/Oceania.
- Strong gross margin of 46.2% indicates efficient production and pricing power.
- Consistent dividend yield of 4.01% suggests financial stability and commitment to shareholder returns.
Bear Case
- Relatively small market capitalization of $365M compared to larger industry players, potentially limiting scale advantages.
- Reliance on the highly specialized and competitive dental market, subject to economic fluctuations affecting elective procedures.
- Disclosure status on the OTC market is 'Unknown', which can hinder investor confidence and transparency.
- Lower profit margin of 6.2% compared to its gross margin, suggesting potential inefficiencies in operating expenses.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $138M | $5M | $0.83 |
| Q4 FY2025 | $150M | $13M | $2.18 |
| Q2 FY2025 | $145M | $5M | $0.87 |
| Q4 FY2024 | $150M | $12M | $2.06 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis · Converted to USD from CHF at today's rate
CLHLF Latest News
-
Coltene Holding AG (XSWX:CLTN) (H1 2026) Earnings Call Highlights: Solid Performance Amid ...
Yahoo! Finance: CLHLF News · Aug 4, 2026
-
The Returns At COLTENE Holding (VTX:CLTN) Aren't Growing
Yahoo! Finance: CLHLF News · Jan 9, 2026
CLHLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CLHLF.
Price Targets
Wall Street price target analysis for CLHLF.
CLHLF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CLHLF; grades run from A+ (80-100) to F (below 30).
Leadership: Dominik Arnold
CEO
Dominik Arnold serves as the Chief Executive Officer of COLTENE Holding AG, where he is responsible for leading the company's global operations and strategic direction. His leadership oversees a workforce of 1176 employees, driving the development, manufacturing, and distribution of dental disposables, tools, and equipment worldwide.
Track Record: Under Dominik Arnold's leadership, COLTENE Holding AG continues to operate as a key provider in the dental industry, maintaining its broad product portfolio and global market presence. His tenure is marked by the ongoing management of a diverse product range, including advanced restoration, endodontics, and infection control solutions, catering to dentists and dental laboratories across multiple continents. The company's consistent financial metrics, such as a 4.01% dividend yield, reflect a stable operational strategy during his leadership.
CLHLF OTC Market Information
COLTENE Holding AG trades on the OTC (Over-The-Counter) market under the 'OTC Other' tier. This tier is typically for companies that do not meet the listing requirements for higher OTC tiers like OTCQX or OTCQB, or for those that choose not to provide extensive financial disclosures. Unlike exchanges such as the NYSE or NASDAQ, which have strict listing standards for market capitalization, share price, and corporate governance, the OTC market has varying levels of disclosure and regulatory oversight. The 'OTC Other' tier generally implies less stringent reporting requirements compared to the more transparent OTCQX or OTCQB tiers, which often require audited financials and compliance with U.S. securities laws.
- OTC Tier: OTC Other
- **Limited Transparency**: The 'Unknown' disclosure status on the OTC market means less financial and operational information may be publicly available, making it harder for investors to assess the company's true financial health and performance.
- **Lower Liquidity**: OTC Other stocks often have lower trading volumes, which can lead to wider bid-ask spreads and difficulty in executing trades at desired prices, especially for larger positions.
- **Regulatory Oversight**: OTC markets generally have less stringent regulatory oversight compared to major exchanges, potentially exposing investors to higher risks of fraud or less robust corporate governance.
- **Price Volatility**: Due to lower liquidity and less information, OTC stocks can be more susceptible to significant price fluctuations based on limited trading activity or news.
- **Difficulty in Valuation**: The scarcity of comprehensive, regularly updated financial data can complicate accurate valuation, increasing the risk of mispricing the stock.
- Verify the company's official website for any investor relations sections or direct financial reports.
- Search for independent news articles, press releases, or regulatory filings (if any exist) from the company's home country (Switzerland).
- Examine any available annual reports or financial statements, even if not standardized to U.S. GAAP or IFRS.
- Assess the company's business operations, product lines, and market position based on non-financial information.
- Investigate the management team's background and track record through publicly available professional profiles.
- Understand the specific risks associated with investing in a foreign company trading on a lower-tier OTC market.
- Consult with a financial advisor experienced in OTC and international investments.
- **Established Operations**: COLTENE Holding AG is an incorporated entity (2005) with a physical headquarters in Altstätten, Switzerland, and a defined business of manufacturing and selling dental products globally.
- **Tangible Products and Services**: The company offers a wide range of specific dental disposables, tools, and equipment, indicating a real business with physical assets and a customer base.
- **Employee Count**: With 1176 employees, COLTENE demonstrates a significant operational scale and workforce, suggesting a legitimate and active enterprise.
- **Global Reach**: Operations across multiple continents (Europe, Americas, Asia/Oceania, Middle East, Africa) indicate a substantial and diversified business, not a shell company.
- **Financial Metrics**: The presence of reported financial metrics like Market Cap ($365M), P/E (20.47), Profit Margin (6.2%), Gross Margin (46.2%), and Dividend Yield (4.01%) suggests a functioning business with measurable performance, even if disclosure status is 'Unknown'.
COLTENE Holding AG Healthcare Stock: Key Questions Answered
Is CLHLF a good stock?
Stock Expert AI does not rate CLHLF buy, sell or hold. COLTENE Holding AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the primary risks associated with investing in COLTENE Holding AG, particularly as an OTC stock?
Investing in COLTENE Holding AG carries several risks, compounded by its trading on the OTC market. Economically, the company is susceptible to downturns that reduce consumer spending on elective dental procedures, impacting demand for its products. The dental supplies market is highly competitive, leading to continuous pressure on pricing and market share from both larger and niche players.
What are the key factors to evaluate for CLHLF?
Evaluate CLHLF on fundamentals, analyst consensus, and risk factors. P/E: 20.47x vs the S&P 500's ~20-25x. The profit margin of 6.2% reflects its ability to convert sales into net income. Not financial advice.
How frequently does CLHLF data refresh on this page?
CLHLF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CLHLF's recent stock price performance?
COLTENE Holding AG (CLHLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio covering multiple dental specialties, reducing reliance on single product lines. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CLHLF overvalued or undervalued right now?
COLTENE Holding AG (CLHLF) trades at 20.47x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of CLHLF?
Yes, most major brokerages offer fractional shares of COLTENE Holding AG (CLHLF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CLHLF's earnings and financial reports?
COLTENE Holding AG (CLHLF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for CLHLF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Specific market sizes and timelines for growth opportunities were not in the source data, so general timelines and market drivers were inferred.
- The 'Unknown' disclosure status for the OTC stock limits the depth of analysis on transparency and liquidity, relying on general OTC market characteristics.